Clarus Therapeutics Holdings, Inc.

Clarus Therapeutics Holdings, Inc., trading under the ticker BLUW, filed an S-1 registration statement with the U.S. Securities and Exchange Commission on September 30, 2021, under accession number 0001213900-21-050782. The company is affiliated with the healthcare and life sciences sector, with an operational focus on therapeutics and pharmaceutical development. The S-1 filing represents a key disclosure event in the company's public capital markets lifecycle, occurring during a period of elevated SPAC activity in the biotech and pharma space. Sponsor details were not confirmed from the available filing metadata. For the complete deal record, sponsor identity, and current status on BLUW and hundreds of other SPAC vehicles, sign up for full data on SpacDesk.